# China NMPA Drug Inspection - Ruiyang Pharmaceutical Co., Ltd. - Amoxicillin capsules

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/ruiyang-pharmaceutical-co-ltd/dc111721-739a-4557-ab44-196a25e01fb5/
Source feed: China

> China NMPA drug inspection for Ruiyang Pharmaceutical Co., Ltd. published June 17, 2021. Drug: Amoxicillin capsules. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Guangdong Provincial Drug Administration's Announcement Regarding Drug Sampling and Inspection Information (Issue 4, 2021)
- Company Name: Ruiyang Pharmaceutical Co., Ltd.
- Publication Date: 2021-06-17
- Drug Name: Amoxicillin capsules
- Inspection Finding: Meets the requirements of drug standards (qualified)
- Action Taken: It does not involve the investigation and handling of substandard drugs.

Company: https://www.globalkeysolutions.net/companies/ruiyang-pharmaceutical-co-ltd/18801bfc-c047-484c-8a9d-be9df274b244/